✦ LIBER ✦

5017 Multinational study (n = 2041) of first-line bevacizumab (Bev) plus taxane-based chemotherapy (CT) for locally recurrent or metastatic breast cancer (LR/mBC): updated results of MO19391

✍ Scribed by H. Cortes-Funes; K.I. Pritchard; L. Biganzoli; C. Thomssen; J. Pierga; I. Koza; A. Kwong; P. Kellokumpu-Lehtinen; A. Chlistalla; I. Smith

Book ID: 119600667
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 68 KB
Volume: 7
Category: Article
ISSN: 1359-6349
DOI: 10.1016/s1359-6349(09)70909-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

2123 POSTER MO19391: an open-label safet

2123 POSTER MO19391: an open-label safety study of bevacizumab plus taxane monotherapy or in combination as first-line treatment of patients with locally recurrent or metastatic breast cancer (LR or MBC)

✍ I.E. Smith; L. Biganzoli; H. Cortes-Funes; F. Franke; Y. Mostafa Kamel; J.Y. Pie 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 57 KB